UiPath is a leading software company in the field of Robotic Process Automation (RPA) that is revolutionizing how businesses operate and innovate by making them more productive. RPA is already ...
UiPath (NYSE: PATH) is a tiny company compared to Microsoft. The stock of the maker of robotic process automation (RPA) software is only worth $7.2 billion, while the diversified tech titan is worth a ...
UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been positioned by Gartner, Inc. as a Leader in the 2025 Gartner® Magic Quadrant™ for ...
Imagine a David Attenborough style narration as a small bot emerges, blinking, into the daylight. It begins to use rudimentary tools, does as it is told, before being joined by a more sophisticated ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation software company, today announced it has been named a Leader in The Forrester Wave™: Robotic Process Automation, Q1 2023 ...
So I wrote an epic missive on the absurdity of AI agent overhype, hopped on a plane to Vegas, to hear UiPath make splashy news announcements about... AI agents. How did that go over with me? A bit ...
UiPath's robotic process automation platform could be displaced by sophisticated AI tools. UiPath has embraced AI, integrating it into its platform and mitigating the downsides. UiPath could emerge as ...
UiPath, Inc. PATH continues to be a dominant force in the rapidly growing Robotic Process Automation (RPA) market, which QKS Group projects will reach a valuation of $7.9 billion by 2030, witnessing a ...
Enterprise automation is stepping back into the spotlight as companies grapple with the realities of artificial intelligence. UiPath Inc., a leader in robotic process automation, is among those ...
UiPath Inc. PATH is trading at a discount that growth investors shouldn't ignore. With a forward 12-month price-to-sales (P/S) ratio of just 4.18X — well below the industry average of 5.85X — UiPath ...